DoubleJump Interchange™: R&D Acceleration

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

Enabling collaboration. Powering healthier lives.

Gain secure access to all clinical, research and NLP-derived data in one platform to accelerate insight generation, discover new biomarkers and optimize clinical trial protocol designs.

Surface novel insights

Accelerate precision medicine programs by collaborating with renowned institutions.

Improve likelihood of favorable study outcomes through adaptive clinical trials.

Optimize protocol design by simulating and tuning protocol (inclusion/exclusion) design using integrated patient profiles.

Drive cross-industry impact

Pharma & Life Science

Expand the breadth and depth of information accessible across the enterprise and across external collaborators; improve the quality and quantity of drug candidates with improved probability of success, time to market, and post-market risk profile
68% of pharma executives say that data sharing partnerships with other organizations will be important to their success

—PwC’s Health Research Institute
 

Our Impact

Biomarker Discovery
Identify disease biomarkers and related treatment pathways to enable precision therapies that improve health outcomes and reduce adverse events.

Patient Registry Consortium
Accelerate R&D discovery and development by collaborating with renowned institutions to access high quality and comprehensive patient data.

Protocol Design and Simulation
Improve likelihood of trial success by simulating and tuning protocol (inclusion/ exclusion) design based on integrated patient profile (clinical and genomic).

Adaptive Clinical Trials
Monitor study outcomes and side effects in real time and modify study parameters according to a predetermined trial protocol.

Academic & Research Institutes

Provide researchers patient-authorized access to comprehensive, integrated, clinical, genomic, laboratory, and image data to enhance insights on disease biology and mechanisms of action
76% of providers believe strengthening data & analytics capabilities will be important to their organization’s success

—PwC’s Health Research Institute
 

Our Impact

Biomarker Discovery
Identify disease biomarkers and related treatment pathways to deliver precision medicine that improve health outcomes and reduce adverse events.

Patient Registry Consortium
Form information-sharing collaborations across multiple Academic Medical Centers and Pharma to gain a more comprehensive view of common and rare diseases across populations, and gain new insights.

Real-World Data Sharing
Enable sharing of real-world data (such as EMR, patient reported outcomes) to unlock therapies that address the personalized needs of every patient.

Connect and collaborate

Virtual Workbench

PwC’s Virtual Workbench tool enables researchers to access data across varied sources to build, save and share cohorts. Researchers are equipped with exploration, analytics and visualization features that help speed the identification of actionable insights.

Contact us

Mark Mynhier

Mark Mynhier

Principal and General Manager, PwC US

Robert Fassett

Robert Fassett

Clinical Informatics & Data Strategy Lead, PwC US

Moriah Nell

Moriah Nell

Business Development & Strategic Partnerships Lead, PwC US

Kelechi Nwoku

Kelechi Nwoku

Clinical Informatics Lead, PwC US

Follow us